|
Dr. Halak joined Domain Associates in 2001 and currently serves as a director of Alimera Sciences, GI Dynamics, and Vanda Pharmaceuticals. He is also a board observer with Iomai and Cell Biosciences. Prior to joining Domain, he worked for Advanced Technology Ventures, where he participated in the firm's investments in Plexxcion, Percardia, and Denovis. Earlier, he worked at the Wilkerson Group, a management consulting firm devoted exclusively to the medical industry. Dr. Halak developed strategy for leading firms in the pharmaceutical, biotechnology, and medical device industries. He received a Ph.D. in immunology and has published and presented on the topic of tumor immunology. He also serves on the investment advisory councils for Ben Franklin Technology Partners and BioAdvance in Philadelphia. | 